Overexpressing GPR68 in MCF7 breast cancer cells (which endogenously lack GPR68) inhibited cell migration by a Gα12/13-Rho-Ras-related C3 botulinum toxin substrate 1 (Rac1) pathway [47]. Here, RAC1 is linked to breast cancer.